Neuropsychopharmacology the first fifty years

. Utilisation en thérapeutique d’une phénothiazine d’action centrale selective. Ann Med Psychol (Paris) 1952; 110: 112–7.
Delay J, Deniker P, Harl JM. Traitement des états d’excitation et d’agitation par une méthode médicamenteuse dérivé de l’hibernothérapie. Ann Med Psychol (Paris) 1952; 110: 267–73.
Delay J, Deniker P, Harl JM, Grasset A. Traitements d’états confusionnels par l’chlorhydrate de diméthylaminopropyl-N-chlorophénothiazine (4560 RP). Ann Med Psychol (Paris) 1952; 110: 112–7.
Delay J, Laine B, Buisson JF. Note concernant l’action de l’isonicotinyl dans le traitement des états dépressives. Ann Med Psychol (Paris) 1952; 110; 689–92.
Erspamer V, Asero B. Identification of enteramine, specific hormone of enterochromaffin cells as 5-hydroxtryptamine. Nature 1952; 169: 800-1.
Flaherty JA. The psychiatric use of isonicotinic acid hydrazide: a case report. Del Med J 1952; 24: 298–300.
Jellinek EM. Phases of alcohol addiction. QJ Study of Alcohol 1952; 131: 673-84.
Laborit H, Huguenard P, Alluaume R. Un nouveau stabilisateur végétatif (le 4560 RP). Presse Méd 1952; 60: 206–8.
Műller JM, Schlittler E, Bein HJ. Reserpin der sedative wirkstoff aus Rauwolfia serpentine Benth. Experientia 1952; 8: 338–9.
Selikoff IJ, Robitzek FH, Orenstein GG. Treatment of pulmonary tuberculosis with hydrazine derivatives of isonicotinic acid. JAMA 1952; 150: 973–80.
Zeller EA, Barsky JR, Fouts W, Kirchheimer WP, Van Orden LS. Influence of isonicotinic acid hydrazide (INH) and 1-isonicotinyl-2-isopropyl hydrazide (IIH) on bacterial and mammalian enzymes. Experientia 1952; 8: 349–50.
WiklerA. A psychodynamic study of a patient during experimental self-regulated re-addiction to morphine. Psychiatric Quarterly 1952; 26: 270-93.
1953
Alexander L. Treatment of Mental Disorders. Philadelphia: Saunders; 1953.
Bradley PB, Elkes J. The action of amphetamine and D-lysergic acid diethylamide (LSD 25) on the electrical activity of the brain of the conscious cat. J Physiol (London) 1953; 120: 13–4.
Delay J, Laine R, Buisson JF. Anxiety and depressive states treated with 1-isonicotinylhydrazide (isoniazid). Arch Neurol Psychiat 1953; 70: 317-24.
Dews PB. The measurement of the influence of drugs on voluntary activity in mice. Br J Pharmacol 1953; 8: 46–8.
Dott FH. Der Blutspiegel-Kinetic der Konzentrationsabläufe in der Krieslauffűsigkeit. Leipzig: Thieme; 1953.
Effron AS, Freedman AM. The treatment of behavior disorders in children with Benadryl. J Pediat 1953; 42: 261-6.
Flűgel F. Neue klinische Beobachtungen zur Wirkung des Phenothiazinkorpere Megaphen auf psychische Krankheitsbilder. Medizinische Klinik 1953; 48; 1027-9.
Fox HH, Gibbas JT. Synthetic tuberculostats. VII. Monoalkyl derivatives of isonicotinylhydrazine . J Org Chem 1953; 18: 992-1002.
Gaddum JH. Antagonism between lysergic acid diethylamide and 5-hydrxytryptophan. J Physiol (London) 1953; 121: 15-8.
Gould WL, Strosberg L. Female senility. Report on series of 217 cases using Glutest, a new fortified androgen. NY State J Med 1953; 53: 661-6.
Humphrey AG, O’Hagan D. Tropane WM. Clinical characteristics of addiction. Amer J Med 1953; 14: 558.
Isbell H. A specific narcotic antagonist, clinical and pharmacologic studies. Merck Report 1953; 62: 23-6.
Isbell H, White WM. Clinical characteristics of addiction. Am J Med 1953; 14: 558-65.
Levy S. Pharmacological treatment of aged patients in a state mental hospital. JAMA 1953; 153: 1260-5.
Salter HM, Lurie ML. Anxiety and depressive states treated with isonicotinyl hydrazide (isoniazid). Arch Neurol Psychiatry 1953; 70: 317–24.
Seevers MH, Woods LA. The phenomena of tolerance. Am J Med 1953; 5: 546-57.
Twarog BM, Page IH. Serotonin content of some mammalian tissues and urine and a method for its determination. Am J Physiol 1953; 175: 157-61.
Wikler A, Fraser HF, Isbell H. N-Allylmorphine effects of single doses and precipitation of “abstinence syndrome “ during addiction to morphine, methadone and heroin in man (post addicts). J Pharmacol Exp Ther 1953; 109: 92-101.
Wikler A, Rasor RW. Psychiatric aspects of drug addiction. Amer J Med 1953; 1: 556-70.
Zetler G. Substance P in the central nervous system. Naturwissenschaften 1953; 40: 559-60.
1954
Amin AH, Crawford TB, Gaddum JH The distribution of substance P and 5- hydroxytryptamine in the central nervous system of the dog. J Physiol 1954; 126: 596-618.
Bente D, Itil TM. Zur Wirkung des Phenothiazin Körpers Megaphen und das menschliche Hirnstrombild. Arzneimittel Forschung 1954; 4: 418-23.
Berger FM. The pharmacodynamic properties of 2-methyl-2-n-1, 3 popanediol dicarbamate (Miltown), a new interneuronal blocking agent. J Pharmacol Exp Ther 1954; 112: 413-23.
Bradley PB, Elkes J. The effects of some drugs on the electrical activity of the brain. Brain. 1954; 80: 77; 117-20.
Bryson RW, Martin DF. 17-Ketosteroid excretion in a case of manic-depressive psychosis. Lancet 1954; 2: 365-6.
Delay J, Deniker P, Tardieu Y, Lemperière Th. Premiers essais en thérapeutique psychiatrique de la réserpine, alcaloide nouveau de la Rauwolfia Serpentina. CR Congr Méd Alién Neurol (France) 1954; 52: 836-41.
Eccles JC, Fatt P, Koketsu K. Cholinergic and inhibitory synapses in a pathway from motor-axon collaterals to motoneurons. J Physiol 1954; 126: 524-62.
Elkes J, Elkes C. Effects of chlorpromazine on the behavior of chronically overactive psychotic patients. Br Med J 1954; 2: 560-76.
Elkes J, Elkes C, Bradley P. The effects of some drugs on the electrical activity of the brain and behaviour. J Ment Sci 1954; 100: 125-8.
Freis ED. Mental depression in hypertensive patients treated for long periods with large doses of reserpine. N Engl J Med 1954; 251: 1006-8.
Gaddum JH, Hamead KA. Drugs which antagonize 5-hydroxytryptamine. Br J Phramacol 1954; 9: 240-8.
Giljarovskij AW. Pszihiatrija. Moscow: Medgiz; 1954.
King EE. Differential action of anesthetic and multineuronal blocking agents on EEG arousal and recruitment responses evoked from the brain stem. Fed Proc 1954; 13: 375-6.
King E, Unna KR. The action of mephenesin and other interneuron depressants on the brain stem. J Pharmacol 1954; 111: 293-301.
Kline NS. Use of Rauwolfia serpentina Benth in neuropsychiatric conditions. Ann NY Acad Sci 1954; 59: 107-32.
Kornetsky C. The effects of anxiety and morphine on the anticipation and perception of painful radiant thermal stimuli. Journal of Comparative and Physiological Psychology 1954; 47: 130-2.
Lasagna L. A comparison of hypnotic agents. J Pharmacol Exp Therap 1954; 111: 9-20.
Lehmann HE, Hanrahan GE. Chlorpromazine, new inhibiting agent for psychomotor excitement and manic states. Arch Neurol Psychiatry 1954; 71: 227-37.
Longo VG, Von Berger GP, Bovet D. Action of nicotine and of the “ganglioplegique centraux” on the electrical activity of the brain. J Pharmacol 1954; 111: 349-59.
Noce RN, Williams DB, Rapaport W. Reserpine (Serpasil) in the management of the mentally ill and the mentally retarded. JAMA 1954; 156: 821-4.
Schou M, Juel-Nielsen N, Strömgren E, Voldby H. The treatment of manic psychosis by the administration of lithium salts. J Neurol Neurosurg Psychiatry 1954; 17: 250-60.
Seevers MA. Adaptation to narcotics. Fed Proc 1954; 13: 672-84.
Steck H. Le syndrome extrapyramidal et diencéphalique au cours des traitements au Largactil et au Serpasil. Ann Med Psychol 1954; 112: 737-43.
Vogt M. Concentration of sympathin in different parts of central nervous system under normal conditions and after administration of drugs. J Physiol 1954; 123: 451-81.
Wikler A, Rayport M. Lower limb reflexes of a “chronic spinal” man in cycles of morphine and methadone addiction. AMA Arch Neurol Psychiatry 1954; 71: 160-70.
Woolley DW, Shaw E. A biochemical and pharmacological suggestion about certain mental disorders. Proc Natl Acad Sci 1954; 40: 238-41.
1955
Abramson AJ, Jarvik ME, Kaufman MR, Kornetsky C, Levine A, Wagner M. Lysergic acid diethylamide (LSD-25) : Physiolgical and perceptual responses. J Psychol 1955; 39: 3-6.
Arnold OH, Hofmann G. Untersuchungen űber Bernsteinsäuere effekte bei LSD-25-Vergiftungen und Schizophrenia. Wien Z Nervenheilk 1955; 11: 92-3.
Ayd FJ. Treatment of psychiatric patients with Thorazine. South Med J 1955; 48: 177-86.
Bein HV, Herold, W. Efficacy of chlorpromazine in mentally retarded children. AMA Arch Neurol & Psychiat 1955; 74: 363-4.
Bowman RL, Caulfield PA, Udenfriend S. Spectrophotometric assay in the visible and ultraviolet. Science 1955; 122: 32-3.
Brodie BB, Axelrod J, Cooper JR, Gillette L, LaDu BN, Mitoma C, Udenfriend S. Detoxication of drugs and other compounds by liver microsomes. Science 1955; 121: 603-4
Cerletti A, Rothlin E. Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives. Nature 1955; 176: 785-6
Davies DL, Shepherd M. Reserpine in the treatment of anxious and depressed patients. Lancet 1955; 2: 117-20.
Dews PP. Studies on behaviour. I. Differential sensitivity to pentobarbital or pecking performance in pigeons depending on the schedule of reward. J Pharmacol Exp Ther 1955; 113: 393-401.
Elkes J, Eyars JT, Todrick A. On the effect and the lack of effect of some drugs on postnatal development in the rat. In: Waelsch H, editor. Biochemistry of the Developing Nervous System. New York: Academic Press; 1955.
Elkes J, Todrick A. On the development of the cholinesterases in the rat brain. In: Waelsch H, editor. Biochemistry of the Developing Nervous System. New York: Academic Press; 1955.
Foster W, Schultz S, Henderson A. Combined hydrogenated alkaloids of ergot in senile and arteriosclerotic psychoses. Geriatrics 1955; 10: 26-30.
Freedman AM, Efron AS, Bender L. Pharmacotherapy in children with psychiatric illness. J Nerv Ment Dis 1955; 122: 479-85.
Freedman AM, Kramer MW, Robertiello RC, Effron AS. The treatment of behavior disorders in children with Tolserol. J Pediat 1955; 47: 369-72.
Gatski RL. Chlorpromazine in the treatment of mentally maladjusted children. JAMA 1955; 157: 1298-300.
Hollister LE. Combined hydrogenated alkaloids of ergot in mental and nervous disorders associated with old age. Dis Nerv Syst 1955; 16: 1-4.
Hollister LE, Fitzpatrick DF. Oral Metrazol in the psychoses associated with old age. J Am Geront Soc 1955; 3: 197-200
Hollister LE, Krieger GE, Kringel A, Roberts RH. Treatment of schizophrenic reactions with reserpine. NY Acad Sci 1955; 61: 92-100.

.

Isbell H. Medical aspects of opiate addiction. Bull New York Acad Med 1955; 37: 886-901.

Kurland AA. Chlorpromazine in the management of the institutionalized aged psychiatric patients with chronic brain syndrome. Dis Nerv Syst 1955; 16: 336-9.
Lasagna L. The controlled clinical trial. Theory and Practice 1955; 1: 353-67.
Lombard JP, Gilbert JG, Donofrio AF. The effect of glutamic acid upon the intelligence, social maturity and adjustment of a group of mentally retarded children. Amer J Ment Def 1955; 60: 122-32.
Mueller JC, Pryor WW, Gibbons JJ, Orgain ES. Depression and anxiety occurring during Rauwolfia therapy. JAMA 1955; 159: 836–9.
Pletscher A, Shore PA, Brodie BB. Serotonin release as a possible mechanism of serotonin action. Science 1955; 122: 374-5.
Salzer HM, Lurie ML. Depressive states treated with isonicotinyl hydrazide (isoniazid). Ohio State Med J 1955; 51:437–41.
Sarwer-Foner GJ, Ogle W. The use of reserpine in an open psychiatric setting. Can med Assoc J 1955; 73: 187-91.
Seager CP. Chlorpromazine in the treatment of elderly psychotic women. BMJ 1955; 1: 882-4.
Terman LA. Treatment of senile agitation with chlorpromazine. Geriatrics 1955; 10: 520-2.
Woolf LL, Griffiths R, Moncrieff A. Treatment of phenylketonuria with a diet low in phenylalanine. Brit med J 1955; 7: 57-64.
Zahn L. Erfahrungen mit einem zentralen Stimulans (Ritalin) bei cerebralen Altersveränderungen. Berl Gesundheitsblatt 1955; 6: 419-20.
1956
Begg WG, Reid AA. Meratran a new stimulant drug. BMJ 1956; 1: 946-9.
Bender L, Nichtern S. Chemotherapy in child psychiatry. New York State J Med 1956; 56: 2791-5.
Besendorf H, Pletscher A. Beeinflussung zentraler Wirkungen von Reserpin und 5-Hydroxytryptamin durch Isonikotinsäurehydrazide. Helv Physiol Pharmacol Acta 1956; 14: 383-90.
Bliss EL, Migren CJ, Branch CH, Samuels LT. Reaction of the adrenal cortex to emotional stress. Psychosom Med 1956; 18: 56-76.
Bovet D, Longo VG. Pharmacologie de substance reticule du tonic cerebral. In: Proceedings of the 20^th International Congress of Physiology 1956; 1; 306-29.
Brady JV. Assessment of drug effects on emotional behavior. Science 1956; 123: 1033-4.
Bridger WH, Gantt WH. Effect of mescaline on differentiated conditional reflexes. Am J Psychiatry 1956; 113: 352-60.
Brodie BB, Shore PA, Pletscher A. Limitation of serotonin releasing activity to those alkaloids possessing tranquilizing action. Science 1956; 123: 992-3.
Brook GW. Experience with the use of chlorpromazine and reserpine in psychiatry with special reference to the management of extrapyramidal dysfunction. New England Journal of Medicine 1956; 254: 119-26.
de Boor W. Psychopharmakologie und Psychopathologie. Berlin: Springer; 1956. p. 1-291.
Fabing HD, Hawkins JR. Intravenous injection of bufotenin in man. Science 1956; 123: 886-7.
Ferguson JT, Funderburk WH. Improving senile behavior with reserpine and Ritalin. JAMA 1956; 160: 279-83.
Fish MS, Horning JR. Studies of hallucinogenic snuffs. J Nerv Ment Dis 1956; 124-37
Gershon S, Trautner EM. Treatment of shock dependency by pharmacological agents. Med J Aust 1956; 43: 783-7.
Gottschalk LA, Knapp FT, Ross WD, et al. Explorations in testing drugs affecting physical and mental activity. Studies with a new drug of potential value in psychiatric illness. JAMA 1956; 161: 1054-8.
Gyermek L, Lázár GT, Csák Zs. The antiserotonin action of chlorpromazine and some other phenothiazine derivatives. Arch Int Pharacodyn 1956; 107: 62-74.
Hollister LE, Traub L, Beckman WG. Psychiatric use of reserpine and chlorpromazine: results of double-blind studies. In: Kline N, editor. Psychopharmacology. Washington: American Association for Advancement of Science; 1956. p. 66-75.
Holzbauer M, Vogt M. Depression by reserpine of the noradrenaline concentration in the hypothalamus of the rat. J Neurochem 1956; 1: 8-11.
Isbell H, Martin WR. Studies on LSD25 effects to former morphine addicts and development of tolerance during chronic administration. Arch Neurol Psychiat 1956; 76: 468-78.
Killam KF. Studies of LSD and chlorpromazine. Psychiat Res Rep 1956; 6: 35–45.
King EE. Differential action of anesthetics and interneuron depressants upon EEG arousal and recruitment responses. J Pharmacol Exp Ther 1956; 116: 404–17.
Kleemeier RW, Rich TA, Justin WA. Effect of α-(2-piperidyl)-benzhydrol hydrochloride (Meratran) on psychomotor performance in a group of aged males. J Geront 1956; 1: 165-70.
Kurland AA. Comparison of chlorpromazine and reserpine in the treatment of schizophrenia. Arch Neurol Psychiatry 1956; 75: 510-3.
Lasagna L. A study of hypnotic drugs in patients with chronic diseases. J Chron Dis 1956; 3:

122-33.
Lyttle GG. Apomorphine treatment of alcoholism. Brit Med J 1956; 2: 1056-7.

Olds J, Killam KF, Bachy-Rita F. Self-stimulation of the brain used as a screening method for tranquilizing drugs. Science; 1956; 124: 265-6.
Pletscher A. Beeinflussung des 5-Hydroxytryptamin-stoffwechsels im Gehirn durch Isonikotinsäurehydrazide. Experientia 1956; 12: 479–80.
Pletscher A, Shore PA, Brodie BB. Serotonin as a modulator of reserpine action in brain. J Pharmacol Exper Ther 1956; 116: 84-9.
Popkin RJ. The hydrogenated alkaloids of ergot (Hydergine) in geriatrics. Follow-up study. Am Pract Dig Treat 1956; 7: 1594-7.
Rothlin E. Metabolism of lysergic acid. Nature 1956; 173: 1400-1.
Sarwer-Foner GJ, Ogle W. Psychosis and enhanced anxiety produced by reserpine and chlorpromazine. Can med Assoc J 1956; 75: 526-32.
Szára S. Dimethyltryptamine: its metabolism in man; the relation of its psychotic effect to serotonin metabolism. Experientia 1956; 12: 441-2.
1957
Arnold OH, Hofmann G. Zur Psychopathologie des Dimethyltryptamin. Wien Z Nervenheilk 1957; 13: 438-45.
Axelrod J, Brady RO, Witkop B, Evarts EV. The distribution and metabolism of lysergic acid diethylamide. Annals NY Acad Sci 1957; 66: 435- 44.
Bente D, Itil TM. Elektroenzephalographische Veränderungen unter extrem hochen Reserpinedosen. In: Garrattini S, Ghetti V, editors. Psychotropic Drugs. Amsterdam: Elsevier; 1957. p. 286-94.
Bente D, Itil TM. Vergleichende klinisch electroenzephalographische Untersuchungen mit Pervitin und LSD-25. In: Garrattini S, Ghetti V, editors. Psychotropic Drugs. Amsterdam: Elsevier; 1957. p. 284-5.
Bradley PB, Elkes J. The effects of some drugs on the electrical activity of the brain. Brain 1957; 80: 77-117.
Brill H, Patton RE. Analysis of 1955-56 population fall in New York State Mental Hospitals in the first year of large-scale use of tranquilizing drugs. Am J Psychiatry 1957; 114: 509-17.
Carlsson A, Lindqvist M, Magnusson T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 1957; 180 (4596): 1200-1.
Carlsson A, Rosgren E, Bertler A, Nilsson J. Effects of reserpine on the metabolism of catecholamines. In: Garattini S, Ghetti V, editors. Psychotropic Drugs. Amsterdam: Elsevier; 1957. p. 363-72.
Cook L, Wesley E. Behavioral effects of some psychopharmacological agents. Ann NY Acad` Sci 1957; 66:740–52.
Crane GE. Iproniazid (Marsilid) phosphate a therapeutic agent for mental disorders. Psychiatr Res Reports 1957; 8: 142-54.
Curtis DR, Eccles JC, Eccles RM. Pharmacological studies on spinal reflexes. J Physiol 1957; 136: 420-4.
Elmadjian F, Hope JM, Lawson ET. Excretion of epinephrine and norepinephrine in various emotional states. J Clin Endocr 1957 17: 608-20.
Gaddum JH. Serotonin-LSD interaction. Annals of the New York Academy of Sciences 1957; 66: 643-8.
Garattini S, Ghetti V, editors. Psychotropic Drugs. Amsterdam: Elseviere; 1957. p. 1 – 606
Gerard RW. Drugs for the soul; the rise of psychopharmacology. Science 1957; 125: 201-3.
Heath RG, Martens S, Leach BE, Cohen M, Angel C. Effects on behavior in humans with the administration of taraxein. Am J Psychiatr 1957; 114: 14-24.
Hoffer A, Osmond` H, Callbeck MJ, Kahan L. Treatment of schizophrenia with nicotinic acid and niotinamide. J Clin Exp Psychopath 1957; 18: 131-58.
Jensen E, Kristjansen P, Paerregaard G. Meprobramats wirkning pa neuritiske og senile patienter. Nordiak medicin 1957; 58: 1614-7.
Killam KF. Pharmacological influences upon evoked electrical activity in the brain. In: Garattini S, Ghatti V, editors. Psychotropic Drugs. Amsterdam: Elsevier; 1957. p. 244-51.
Killam EK, Killam KF. The effects of psychotherapeutic compounds on central afferent and limbic pathways. Ann NY Acad Sci 1957; 66: 784-805.
Kuhn R. Über die Behandlung depressives Zustande mit einem iminodibenzyl-derivat (G22355). Schweiz Med Wochenschr 1957; 87: 1135-40.
Lemere F. Aversion treatment of alcoholism. British Journal of Psychiatry 1957; 82: 257-8.
Loomer HP, Sanders JC, Kline NS. A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer. Psychiatr Res Rep Am Psychiatr Assoc 1957; 8: 129-41.
Martin KE, Overly GH, Krone RE. Pipradrol. Combined therapy for geriatric and agitated patients. Int Rec Med 1957; 120: 33-6.
Montagu KA. Catechol compounds in rat tissues and in brains of different animals. Nature 1957; 180: 240-1.
Persky H. Adrenal cortical function in anxious human subjects . Arch Neurol Psychiat 1957; 78: 95-6.
Pletscher A. Release of 5-hydroxytryptamine by benzoquinolizine derivatives with sedative action. Science 1957; 126: 507-8.
Pomeranze J, Ladek RJ. Clinical studies in geriatrics. III. The “tonic”. J Am Geriat Soc 1957; 5: 997-1002
Price DB, Thaler M, Mason JW. Preoperative emotional states and adrenal cortical activity. Arch Neurol Pschiat 1957; 77: 623-34.
Purpura DP, Girado M, Grundfest H. Selective blockade of excitatory synapses in the cat brain by γ-aminobutyric acid. Science 1957: 125: 1200-1.
Rothlin E. Lysergic acid diethylamide and related substances. Annals of the New York Academy of Sciences 1957; 66: 668-76.
Sarwer-Foner GJ. Psychoanalytic theories of activity-passivity conflicts and of the continuum of ego defences: experimental verification using reserpine and chlorpromazine. Arch Neurol Psychiatry 1957; 78: 413-8.
Settel E. Treatment of anxiety and agitation with prochlorperazine in geriatric patients. J Am geriat Soc 1957; 5: 827-31.
Szára S. Comparison of the psychotic effect of tryptamine derivatives with the effects of mescaline and LSD-25 in self-experiments. In: Garattini S, Ghetti V, editors. Psychotropic Drugs. Amstradam: Elsevier; 1957. p. 460-7.
Wikler A. The Relation of Psychiatry to Pharmacology. Baltimore: Williams and

Wilkins; 1957.

1958
Agranoff BW, Bradley RM, Brady RO. The enzymatic synthesis of inositol phosphatide. J Biol Chem 1958; 233: 1077-83.
Billiottet J, Ferrand A. A new synthetic vasodilator and antispasmodic. Preliminary results in vascular therapy. Sem mèd 1958; 34: 635-7.
Birkmayer W, Mentasti M. Clinical experience with a new vasodilator in neurological diseases. Wien med Wschr 1958; 108: 395-6.
Blackman LM, Glenn M, Olinger L. Combined use of a tranquilizer and vitamin in the treatment of elderly psychotic patients. Am J Psychiat 1958; 114: 837-8.
Blanc B. The use of meprobamate in gerontology. Lyon méd 1958; 200: 885-92.
Bradley PB. The.central action of certain drugs in relation to the reticular formation of the brain. In Jasper HH, Proctor LD, Knighton RS, Noshay WC, Costello RT, editors. Reticular Formation of the Brain. Boston: Little Brown & Company; 1958. p. 123–49.
Bradley PB, Key BJ. The effect of drugs on arousal responses` produced by electrical stimulation of the reticular formation of the brain. Electroencephalog Clin Neurophysiol 1958; 10: 97-110.
Bradley PB, Mollica A. The effect of adrenaline and acetylcholine on single unit activity in the reticular formation of the decerebrate cat. Arch Ital Biol 1958; 96: 168–86.
Brodie BB, Maickel RP. Termination of drug metabolism. Federation Proceedings 1958; 17: 1163-4.
Cameron DE. The use of nucleic acid in aged patients suffering from memory impairment. Am J Psychiatry 1958; 114: 943-4.
Carlsson A, Lindquist M, Magnusson T, Waldeck B. On the presence of 3-hydroxytyramine in brain. Science 1958; 127: 471-2.
Catenacci AJ. Evaluation of 1-(1-phenylcyclohexyl )-piperidine (Sernyl) as an anesthetic and pre-anesthetic. Fed Proc 1958; 17: 357-8.
Connell PH. Amphetamine Psychoses. London: Chapman and Hall; 1958.
De Verteuil RL, Lehmann HE. Therapeutic trial of iproniazid (Marsilid) in depressed and apathetic patients. Can Med Assoc J 1958; 78:131-3.
Fink M, Shaw R, Gross G, Coleman FS. Comparative study of chlorpromazine and insulin coma in the therapy of psychosis. JAMA 1958; 166: 1846-50.
Gliedman L, Gantt WH. The effect of reserpine, chlorpromazine and morphine on the orienting response. In: Gantt WH, editor. Physiological Basis of Psychiatry. Springfield: Charles C. Thomas; 1958. p. 196–206.
Harley-Mason J, Laird A, Smythies JR. The metabolism of mescaline in human. Confin Neurol. 1958; 18: 152-5.
Heath RG, Martens S, Leach BE, Cohen M, Fengley CA. Behavioral changes in non-psychotic volunteers following the administration of taraxein a substance` obtained from serum of schizophrenic patients. Am J Psychiat 1958; 114: 17-20
Hofmann A, Frey A, Ott H, Petrzilka T, Troxler F. Konstitutionsaufklärung und Synthese von Psilocybin. Experientia 1958; 15: 397-9.